Filing Details

Accession Number:
0001140361-17-044957
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-12-04 20:26:14
Reporting Period:
2017-11-30
Accepted Time:
2017-12-04 20:26:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1048477 Biomarin Pharmaceutical Inc BMRN Pharmaceutical Preparations (2834) 680397820
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1380710 Eric George Davis C/O Biomarin Pharmaceutical Inc.
770 Lindaro St.
San Rafael CA 94901
Evp, General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-11-30 1,200 $85.64 82,942 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. All shares sold at the same price.
  2. Amount of securities beneficially owned has been updated from the reporting person's prior report to: a) include 804 shares reported in the Form 4 Amendment filed with the S.E.C. on 10/13/2017; and b) exclude 243 shares inadvertently included in prior reports based on a reconciliation with the Company's records.